Jeffrey Scott Riley, CEO and President at Synthetic Biologics, Inc. (SYN), bought 5,500 shares at $1.75 ($10K) on 2013-01-03, disclosed to the SEC on 2013-01-03.
Open-market purchase of $10k SYN by CEO and President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.78 | 2,700 | $5K | 49.5% |
| 2 | $1.75 | 2,800 | $5K | 50.5% |
| Total | $1.76 avg | 5,500 | $10K | 100% |
| Filing → |
| SYN | BUY | 2013-01-04 | $3K | — | Filing → |